Advertisement
Australia markets closed
  • ALL ORDS

    8,153.40
    +59.10 (+0.73%)
     
  • ASX 200

    7,921.30
    +60.10 (+0.76%)
     
  • AUD/USD

    0.6551
    +0.0010 (+0.15%)
     
  • OIL

    76.44
    -1.84 (-2.35%)
     
  • GOLD

    2,385.70
    +32.20 (+1.37%)
     
  • Bitcoin AUD

    105,914.69
    +2,463.38 (+2.38%)
     
  • CMC Crypto 200

    1,399.25
    +68.65 (+5.15%)
     
  • AUD/EUR

    0.6029
    +0.0004 (+0.06%)
     
  • AUD/NZD

    1.1118
    +0.0019 (+0.17%)
     
  • NZX 50

    12,349.47
    -46.80 (-0.38%)
     
  • NASDAQ

    19,023.66
    +193.07 (+1.03%)
     
  • FTSE

    8,285.71
    +99.36 (+1.21%)
     
  • Dow Jones

    40,589.34
    +654.27 (+1.64%)
     
  • DAX

    18,417.55
    +118.83 (+0.65%)
     
  • Hang Seng

    17,021.31
    +16.34 (+0.10%)
     
  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.